Health Catalyst, Inc.
HCAT
$4.11
-$0.32-7.22%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 4.26% | 0.59% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.26% | 0.59% | |||
| Cost of Revenue | 6.23% | 5.71% | |||
| Gross Profit | 1.84% | -5.06% | |||
| SG&A Expenses | 9.16% | -5.89% | |||
| Depreciation & Amortization | 2.83% | -6.32% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.62% | 0.62% | |||
| Operating Income | -21.39% | -0.82% | |||
| Income Before Tax | -31.89% | -13.05% | |||
| Income Tax Expenses | 231.58% | -778.57% | |||
| Earnings from Continuing Operations | -40.38% | -8.95% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -40.38% | -8.95% | |||
| EBIT | -21.39% | -0.82% | |||
| EBITDA | -49.31% | -25.99% | |||
| EPS Basic | -36.04% | -6.89% | |||
| Normalized Basic EPS | -22.64% | -38.21% | |||
| EPS Diluted | -36.04% | -6.89% | |||
| Normalized Diluted EPS | -22.64% | -38.21% | |||
| Average Basic Shares Outstanding | 3.20% | 1.92% | |||
| Average Diluted Shares Outstanding | 3.20% | 1.92% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
